Epidemiology and potential for prevention of abdominal aortic aneurysm

ABM Wilmink, CRG Quick - British Journal of Surgery, 1998 - Wiley Online Library
Background Ruptured abdominal aortic aneurysm (AAA) is a common cause of death which
is preventable by elective repair of an asymptomatic AAA. Methods The literature was …

Pharmacotherapy in clinical trials for abdominal aortic aneurysms: A systematic review and meta-analysis

Z Su, J Guo, Y Gu - Clinical and Applied Thrombosis …, 2022 - journals.sagepub.com
Objective There is no medical treatment proven to limit abdominal aortic aneurysm (AAA)
progression. This systematic review aimed to summarise available trial evidence on the …

Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with abdominal aortic aneurysms: nation-wide cohort study

KE Kristensen, C Torp-Pedersen… - … , and vascular biology, 2015 - Am Heart Assoc
Objective—The renin–angiotensin system is thought to play a pivotal role in the
pathogenesis of abdominal aortic aneurysms (AAAs). However, effects of angiotensin …

The incidence of abdominal aortic aneurysms

K Stevens - International Journal of Clinical Practice, 1993 - Wiley Online Library
The incidence of abdominal aortic aneurysms (AAAs) is increasing, especially in the elderly.
This trend has been observed in the United Kingdom, 1 USA, 2 Australia, 3, 4 and Sweden5 …

Preadmission use of renin–angiotensin blockers and rupture of abdominal aortic aneurysm: a nationwide, population‐based study

H Wemmelund, A Høgh, HH Hundborg… - … and Drug Safety, 2016 - Wiley Online Library
Purpose Rupture of abdominal aortic aneurysms (rAAA) is associated with high mortality.
Use of angiotensin converting enzyme inhibitors (ACE‐inhibitors) and angiotensin receptor …

Mortality and size of abdominal aortic aneurysm at long-term follow-up of patients not treated surgically and treated with and without statins

R Sukhija, WS Aronow, R Sandhu, P Kakar… - The American journal of …, 2006 - Elsevier
Of 130 patients with abdominal aortic aneurysms (AAAs) not treated surgically, 75 (58%)
were treated with statins. The sizes of the AAAs were 4.6±0.6 cm at baseline and 4.5±0.6 cm …

Benefits of reducing the cardiovascular risk in patients with abdominal aortic aneurysm

S Cinza-Sanjurjo… - European Journal of …, 2022 - academic.oup.com
An abdominal aortic aneurysm (AAA) is a pathological irreversible dilation of the abdominal
aorta, which diameter is at least 3 cm or more than 1.5 times the normal antero-posterior …

The influence of statins on the expansion rate and rupture risk of abdominal aortic aneurysms

JP Van Kuijk, WJ Flu, OP Witteveen… - Journal of …, 2009 - search.proquest.com
Abdominal aortic aneurysms (AAA) have a prevalence between 1.3-8.9% in men and 1.0-
2.2% in women aged above 55 years. Furthermore, AAA cause 1-3% of all deaths among …

Abdominal aortic aneurysms and risk factors for adverse events

R Ahmed, K Ghoorah, V Kunadian - Cardiology in Review, 2016 - journals.lww.com
An abdominal aortic aneurysm (AAA) is a focal full thickness dilatation of the abdominal
aorta, greater than 1.5 times its normal diameter. Although some patients with AAA …

[HTML][HTML] An analysis of drug modulation of abdominal aortic aneurysm growth through 25 years of surveillance

A Thompson, JA Cooper, M Fabricius… - Journal of vascular …, 2010 - Elsevier
BACKGROUND: A modest (41%) reduction in abdominal aortic aneurysm (AAA) growth rate
is likely to delay AAA-related events (surgery or rupture) by 5 years, making the notion of …